Ishan Hirji

3PUBLICATIONS
0CO-AUTHORS
Epidemiological modellingRespiratory diseasesGene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Mar 06, 2024
A time trade-off study to determine health-state utilities of transplant recipients with refractory cytomegalovirus infection with or without resistance.

Waqas Ahmed, Louise Longworth, Yemi Oluboyede

|Sep 01, 2023
Retrospective chart review of transplant recipients with cytomegalovirus infection who received maribavir in the Phase 3 SOLSTICE trial: Data at 52 weeks post-maribavir treatment initiation.

Marielle Bassel, Dorothy Romanus, Tien Bo

|May 08, 2023
Healthcare resource utilization of maribavir versus investigator-assigned therapy in transplant recipients with cytomegalovirus infection refractory (with or without genotypic resistance) to prior treatment: Exploratory analysis of the Phase 3 SOLSTICE trial.

Ishan Hirji, Kim Cocks, Alejandro Moreno-Koehler

Pageof 1

Frequent Collaborators